US companies drive 2023 drug launches positioned for blockbuster success by 2028

According to GlobalData's Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 …

AION Labs and BioMed X launch sixth challenge for AI-driven drug discovery

Last week, artificial intelligence (AI) innovator AION Labs called for applications for its latest AI-powered startup. In partnership with BioMed …

Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter

Catalent’s (Somerset, NJ, US) CEO has admitted to the company’s “disappointing” and “poor performance” over the past quarter, and dropped …

Abiogen acquires EffRx to fortify bone disease portfolio

The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals …

AstriVax received €2.5 million government grant for thermostable vaccines

AstriVax has received a €2.5 million government grant from the Flanders Innovation & Entrepreneurship (VLAIO) agency that will be used …